Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D-Reference-Cited by-同舟云学术

Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D

Published:2010-10-29 Issue:5 Volume:68 Page:629-638
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Mendell Jerry R.,Rodino-Klapac Louise R.,Rosales Xiomara Q.,Coley Brian D.,Galloway Gloria,Lewis Sarah,Malik Vinod,Shilling Chris,Byrne Barry J.,Conlon Thomas,Campbell Katherine J.,Bremer William G.,Taylor Laura E.,Flanigan Kevin M.,Gastier-Foster Julie M.,Astbury Caroline,Kota Janaiah,Sahenk Zarife,Walker Christopher M.,Clark K. Reed

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference19 articles.

1. Two decades of clinical gene therapy-success is finally mounting;Herzog;Discov Med,2010

2. Construction and analysis of compact muscle-specific promoters for AAV vectors;Wang;Gene Ther,2008

3. Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors;Hauser;Mol Ther,2000

4. Limb-girdle muscular dystrophies-from genetics to molecular pathology;Laval;Neuropathol Appl Neurobiol,2004

5. Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D);Carrié;J Med Genet,1997

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced therapeutic approaches in sarcoglycanopathies;Current Opinion in Pharmacology;2024-06

2. Newborn Screening for Neuromuscular Disorders, Disorders of Glycogen Metabolism, and Fatty Acid Oxidation;OBM Genetics;2024-04-18

3. Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study;BMC Neurology;2024-03-15

4. Use of plasmapheresis to lower anti-AAV antibodies in nonhuman primates with pre-existing immunity to AAVrh74;Molecular Therapy - Methods & Clinical Development;2024-03

5. Detection of Humoral Response to Transgene Protein and Gene Editing Reagents;Drug Development for Gene Therapy;2024-02-16